Therefore, DPP4 inhibitors for the treatment of T2DM also had great success, being highly effective through mechanisms involving not only an augmented half-life of incretins but also by additional mechanisms [28]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.